26 completed, 7 terminated, 5 unknown, 4 recruiting. 45 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 45 | Completed 26, Terminated 7, Unknown 5, Recruiting 4, Withdrawn 2, Active not recruiting 1 |
Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Unbound Cloxacillin Concentrations During Continuous Infusion Unbound cloxacillin concentration - Staphylococcal Infections | Phase 4 | Recruiting | Emeli Månsson | 25 | 2026-01-14 | 2026-02-17 |
| Decolonization Efficacy of Polyhexanide vs. Mupirocin Polyhexanide, Mupirocin and Chlorhexidine - Staphylococcus Aureus, Colonization, Asymptomatic | Phase 4 | Completed | Swiss Paraplegic Research, Nottwil | 24 | 2025-05-01 | 2026-07-08 |
| Staph Intervention for Effective Local Defense Mupirocin + Nozin + chlorhexidine gluconate, Education + Household supplies - Staphylococcus Aureus Infection | Phase 4 | Completed | Johns Hopkins Bloomberg School of Public Health | 78 | 2024-04-01 | 2026-06-12 |
| Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial Clindamycin, Standard of care - Skin Infection, Staphylococcal Infections | Phase 4 | Recruiting | Frieder Schaumburg | 100 | 2024-03-15 | 2024-12-09 |
| Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Dicloxacillin Oral Capsule, Elocon 0.1 % Topical Cream - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Unknown | Jacob Pontoppidan Thyssen | 45 | 2022-10-24 | 2022-12-21 |
| Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP Dupilumab Prefilled Syringe - Nasal Polyps, Staphylococcus Aureus | Phase 4 | Recruiting | University of Virginia | 20 | 2022-09-01 | 2025-04-01 |
| Staphylococcus Aureus Network Adaptive Platform Trial Cefazolin, Penicillin, Clindamycin - Staphylococcus Aureus Bacteremia | Phase 4 | Recruiting | University of Melbourne | 8000 | 2022-02-16 | 2026-05-06 |
| Nasal Decolonization of Dialysis Patients Noses Povidone-Iodine Topical Ointment, Standard Care - Staphylococcus Aureus Infection | Phase 4 | Active not recruiting | Marin L. Schweizer, PhD | 302 | 2020-09-29 | 2023-06-28 |
| Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children PRIVIGEN (CSL Behring), Albumin - Staphylococcal Infection, Streptococcal Infection | Phase 4 | Withdrawn | Hospices Civils de Lyon | 2020-09-01 | 2021-05-03 | |
| Vancomycin Dosage Strategy Based on a Trough Concentration Model Individualized therapy - Pneumonia, Staphylococcal | Phase 4 | Completed | Peking University Third Hospital | 66 | 2019-10-01 | 2022-08-31 |
| Ceftriaxone as Home IV for Staph Infections Ceftriaxone, Usual Antibiotics (Cloxacillin, Cefazolin, Daptomycin) - Staphylococcal Infections, Osteomyelitis | Phase 4 | Unknown | Vancouver Island Health Authority | 310 | 2019-07-11 | 2019-10-28 |
| Penicillin Against Flucloxacillin Treatment Evaluation Benzylpenicillin, Flucloxacillin - Staphylococcus Aureus | Phase 4 | Withdrawn | The University of Queensland | 2019-07-01 | 2022-11-16 | |
| Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery Chlorhexidine, Lifo-Scrub sol 4%®, 500ml, B. Braun, BACTROBAN® Nasal ong - Staphylococcus Aureus, Orthopaedic Surgery | Phase 4 | Completed | Lindenhofgruppe AG | 1318 | 2019-01-01 | 2020-07-17 |
| Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers Decolonization, No decolonization - Hemodialysis Patients | Phase 4 | Terminated | Centre Hospitalier Universitaire de Saint Etienne | 434 | 2018-02-23 | 2024-12-18 |
| Mupirocin-Iodophor ICU Decolonization Swap Out Trial Arm 1. Routine Care (Mupirocin/CHG), Arm 2. Iodophor/CHG Decolonization - Staphylococcus Aureus | Phase 4 | Completed | Harvard Pilgrim Health Care | 353323 | 2017-05-01 | 2025-03-30 |
| PWID; Longitudinal S Aureus Colonization Pattern and the Impact on Infection Frequency by Regular Showers With Chlorhexidine Chlorhexidine Topical - Intravenous Drug Abuse, S Aureus Colonization | Phase 4 | Completed | Lund University | 61 | 2016-12-15 | 2022-04-28 |
| Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia Daptomycin, Placebo - Methicillin Susceptible Staphylococcus Aureus Septicemia, Bacteremia | Phase 4 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 102 | 2016-12-01 | 2020-09-22 |
| Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Ivermectin, Azithromycin, Permethrin - Scabies, Yaws | Phase 4 | Completed | London School of Hygiene and Tropical Medicine | 1291 | 2016-07-01 | 2019-09-17 |
| Effectiveness of an Ultrasonic Denture Hygiene Intervention Program Among Community-dwelling Elders Ultrasonic cleaning, Conventional denture hygiene - Denture, Removable Partial Denture | Phase 4 | Completed | The University of Hong Kong | 66 | 2016-06-20 | 2018-05-11 |
| Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence 2% mupirocin ointment, Chlorhexidine wash, Hygiene protocol - Methicillin-Resistant Staphylococcus Aureus, Recurrence | Phase 4 | Unknown | Clinical Directors Network | 278 | 2015-10-01 | 2017-07-21 |
Showing 20 of 45. Sign in to see all of them.
Abscess (5) · Cellulitis (5) · Staphylococcal Skin Infections (5) · Impetigo (4) · Infections (4) · Bacteremia (3) · Folliculitis (3) · Cross Infection (2) · Dermatitis, Atopic (2) · Furunculosis (2) · Pneumonia, Staphylococcal (2) · Skin Diseases, Infectious (2) · Surgical Wound Infection (2) · Arthritis, Infectious (1)
Bacterial Infections (45) · Bacterial Infections and Mycoses (45) · Gram-Positive Bacterial Infections (44) · Infections (41) · Pathological Conditions, Signs and Symptoms (20) · Pathologic Processes (19) · Skin and Connective Tissue Diseases (14) · Inflammation (11) · Skin Diseases (11) · Skin Diseases, Bacterial (11) · Skin Diseases, Infectious (11) · Suppuration (8) · Staphylococcal Skin Infections (6) · Connective Tissue Diseases (5)
Vancomycin (9) · Daptomycin (8) · Mupirocin (7) · Chlorhexidine (4) · Clindamycin (4) · Rifampin (3) · Standard of Care (3) · chlorhexidine gluconate (3) · Cefazolin (2) · Cloxacillin (2) · Floxacillin (2) · Gentamicins (2) · Linezolid (2) · Penicillin G (2) · 1,1,1,3,3-pentafluoropropane (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Aaron Chen (1) · Albert Einstein Healthcare Network (1) · CPL Associates (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Clinical Directors Network (1) · Columbia University (1) · Destiny Pharma Plc (1) · Emeli Månsson (1) · Frieder Schaumburg (1) · GlaxoSmithKline (1) · Harvard Pilgrim Health Care (1) · Hospices Civils de Lyon (1) · Jacob Pontoppidan Thyssen (1) · Johns Hopkins Bloomberg School of Public Health (1)
United States (22) · France (4) · Germany (4) · United Kingdom (4) · Canada (3) · South Africa (3) · Sweden (3) · Switzerland (3) · Taiwan (3) · Argentina (2) · Australia (2) · Chile (2) · Mexico (2) · Netherlands (2) · Norway (2)
Aaron E Chen, MD (1) · Adelaide A Hebert, M.D. (1) · Christof von Eiff, MD (1) · Daniel M Musher, MD (1) · David Paterson (1) · Dennis G Maki, M.D. (1) · Elisabeth Botelho-Nevers, MD PhD (1) · Eric Partlow, MD, FRCPC (1) · Finnur Snorrason, M.D, Ph.D (1) · Franklin D Lowy, MD (1) · Frieder Schaumburg, MD (1) · Ian Mr Hayter, BSc (1)
PMID 20686410, PMID 22653459, PMID 24011955, PMID 24279701, PMID 25209610, PMID 26196695, PMID 26547411, PMID 27600290, PMID 28314743, PMID 28491950, PMID 29985978, PMID 30037355, PMID 30915685, PMID 32859235, PMID 34862278, PMID 35342110, PMID 36806068, PMID 37815567, PMID 39934879, PMID 41433510, PMID 41635193, PMID 42308484, PMID 42309115
2016 (1), K08AI072043 (1), S06GM142120 (1)